Back to Authors

Melton, Alexis

A5109596142 | I4210091812

Mayo Clinic

Bristol-Myers Squibb (United States)

Citations 2

OC.57 Safety and efficacy of CD19 NEX-T® (BMS-986353), a chimeric antigen receptor (CAR) T cell therapy, in systemic sclerosis (SSc): findings from the breakfree-1 trial

Oral Communications | June 5, 2026 | Volume: No volume available | Issue: No issue available | Pages: A61-A63

10.1136/jsrd-2026-sswc.57

S15:01 Safety and efficacy of CD19 NEX-T® (BMS-986353)—a CD19-directed chimeric antigen receptor (CAR) T cell therapy—for severe refractory systemic lupus erythematosus (SLE): breakfree-1 trial update

Oral Presentations | March 2, 2026 | Volume: No volume available | Issue: No issue available | Pages: A24-A25

10.1136/lupus-2026-el.21